Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170655 | 0.98 | MEN1 (0.37) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL4343033 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL28980881 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL5148527 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL9101740 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL28980882 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL5148506 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL5148510 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL5148520 | 0.97 | MEN1 (0.36) | MEN1KMT2ATHRBAPEX1RECQL | |
| SCHEMBL8666924 | 0.94 | PTGES (0.35) | MEN1KMT2ATHRBAPEX1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117766729-A | Cathode active material layer for lithium secondary battery and method of manufacturing the same | 纳米技术仪器公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-110710023-B | Lithium metal secondary battery comprising anode-protecting polymer layer and method for manufacturing same | 纳米技术仪器公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-110268553-B | Flexible and conformal cable-type alkali metal cell | 纳米技术仪器公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-110692152-B | Alkali metal cell with deformable quasi-solid electrode material | 纳米技术仪器公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-110582872-B | Lithium battery cathode and method of manufacture | 纳米技术仪器公司 | 2023-05-12 | — | — | CN | disclosed |
| US-7135243-B2 | Organic electroluminescent devices | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2006-11-14 | — | — | US | disclosed |
| US-20050212409-A1 | Organic luminescent materials | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY, THE | 2005-09-29 | — | — | US | disclosed |
| US-20050214566-A1 | Organic electroluminescent devices | UNITED STATES GOVERNMENT, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2005-09-29 | — | — | US | disclosed |
| US-6811896-B2 | Organic light emitting device (OLED) with thick (100 to 250 nanometers) porphyrin buffer layer | XEROX CORPORATION | 2004-11-02 | — | — | US | disclosed |
| US-6812638-B2 | PRODUCED AT RELATIVELY LOW TEMPERATURE | PIONEER CORPORATION (JP) | 2004-11-02 | — | — | US | disclosed |
| US-5047687-A | Organic electroluminescent device with stabilized cathode | EASTMAN KODAK COMPANY (US) | 1991-09-10 | — | — | US | disclosed |
| WO-1990014744-A1 | ELECTROLUMINESCENT DEVICE WITH SILAZANE-CONTAINING LUMINESCENT ZONE | EASTMAN KODAK COMPANY (US) | 1990-11-29 | — | — | WO | disclosed |
| US-4950950-A | Electroluminescent device with silazane-containing luminescent zone | EASTMAN KODAK COMPANY (US) | 1990-08-21 | — | — | US | disclosed |
| EP-0349265-A2 | Electroluminescent devices | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-01-03 | — | — | EP | disclosed |
| US-4885211-A | CONTAINING MAGNESIUM AND METAL WITH HIGHER WORK FUNCTION; STABILITY | EASTMAN KODAK COMPANY (US) | 1989-12-05 | — | — | US | disclosed |
| EP-0281381-A2 | Electroluminescent device with modified thin film luminescent zone | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-09-07 | — | — | EP | disclosed |
| US-4769292-A | Electroluminescent device with modified thin film luminescent zone | EASTMAN KODAK COMPANY (US) | 1988-09-06 | — | — | US | disclosed |
| EP-0278758-A2 | Electroluminescent device with organic luminescent medium | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-08-17 | — | — | EP | disclosed |
| EP-0278757-A2 | Electroluminescent device with improved cathode | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-08-17 | — | — | EP | disclosed |
| US-4720432-A | Electroluminescent device with organic luminescent medium | EASTMAN KODAK COMPANY (US) | 1988-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050212409-A1 | Organic luminescent materials | CBR3, GALR3, REL | MEN1 2143/4885KMT2A 2053/4885THRB 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.